Study of BZ371A for women with sexual arousal disorder
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This trial tests a new medication, BZ371A, to see if it can safely improve sexual arousal in women who have a hard time getting or keeping physical signs of arousal like lubrication or clitoral swelling. It is designed for women in a stable relationship who have had previous sexual experiences but now struggle with arousal, and who find this distressing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 21 and 65 years old.
- You have a stable partner for more than 6 months and plan to live with them during the study.
- You have had sexual experiences before (including orgasm, desire, and arousal) for at least 2 years.
- You currently have trouble getting or keeping physical arousal during sex, which upsets you or causes relationship problems.
- You are willing to try to have sex at least twice a week while taking the study medicine.
- You do not have serious relationship problems, untreated sexual trauma, or certain medical conditions like uncontrolled diabetes or recent pelvic surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational medication, BZ371A, to see if it can help women with Female Sexual Arousal Disorder (FSAD), a condition where they have trouble getting or keeping physical signs of arousal like lubrication and warmth. The study aims to find out if BZ371A is safe, effective, and well-tolerated.
This study tests an experimental oral medication, S1B-408, to see if it improves orgasm function in women with orgasmic disorder. It may be a good option if you have trouble achieving orgasm and are looking for a potential new treatment.
This study tests whether a medication called bupropion can help women with hormone receptor-positive breast cancer who are taking aromatase inhibitors (drugs that block estrogen) but experiencing low sexual desire as a side effect. The goal is to see if this approach improves both tolerance to the cancer medication and quality of life.
This study tests a device that uses gentle electrical stimulation to improve sexual function in women. You can use it at home after being trained at the study center.
This study tests an experimental vaginal cream (AZU-101) for postmenopausal women who have vaginal dryness and pain during sex. The goal is to see if it can improve these symptoms without the risks of hormone treatments.
This trial tests whether bazedoxifene can help women with schizophrenia who are stable on their current medicines. You may be asked to do questionnaires and thinking (cognitive) tests to see if symptoms or brain-related measures change.
Hear when a new Female Sexual Arousal Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.